Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) Treatment in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2013-09-30
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 169
- Registration Number
- NCT01952509
A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Drug: PlaceboDrug: RO6811135
- First Posted Date
- 2013-09-26
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT01951183
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
- First Posted Date
- 2013-09-26
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 52
- Registration Number
- NCT01951170
A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma
- First Posted Date
- 2013-09-23
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 54
- Registration Number
- NCT01948401
A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2018-11-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 100
- Registration Number
- NCT01941095
- Locations
- 🇬🇷
Laiko General Hospital; Dept. of Pathophysiology-Uni of Athens, Athens, Greece
🇬🇷Uni Hospital of Ioannina; Rheumatology, Ioannina, Greece
🇬🇷General Hospital of Thessaloniki HIPPOKRATIO; Clinical Immunology Unit,2nd Dept of Internal Medicine, Thessaloniki, Greece
A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration
- Conditions
- Macular Degeneration
- Interventions
- Drug: RO6867461
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT01941082
A Study to Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants
- First Posted Date
- 2013-09-13
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 227
- Registration Number
- NCT01941940
- Locations
- 🇮🇹
Osp S. Maria Misericordia Dip. Medicina Clinica Sperimentale Cattedra Reumatologia, Perugia, Umbria, Italy
🇮🇹Uni Degli Studi Di L Aquila; Cattedra Di Reumatologia - Dept. Di Medicina Interna E San, Coppito, Abruzzo, Italy
🇮🇹Ospedale Regionale Torrette; SOD Clinica Medica del Dipartimento di Medicina Interna e Specialisti, Ancona, Marche, Italy
A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2020-11-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 240
- Registration Number
- NCT01940497
- Locations
- 🇮🇹
Ospedale S.G.Calibita Fatebenefratelli; Unità Operativa Oncologia, Roma, Lazio, Italy
🇮🇹Campus Universitario S.Venuta; Centro Oncologico T.Campanella, Catanzaro, Calabria, Italy
🇮🇹Ospedale San Carlo; Day Hospital Oncologia Medica, Potenza, Basilicata, Italy
An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis
- Conditions
- Anemia
- Interventions
- Drug: Methoxy polyethylene glycol epoetin beta
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2017-07-05
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 98
- Registration Number
- NCT01940484
- Locations
- 🇿🇦
Donald Gordon Medical Centre, Johannesburg, South Africa
🇿🇦Universitas Private Hospital, Bloemfontein, South Africa
🇿🇦Glynnwood Hospital, Benoni, South Africa
A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802
- First Posted Date
- 2013-09-12
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT01940510